ZVRA · Zevra Therapeutics, Inc.

$12.54 -0.01 (-0.04%)

Market Cap

$732.80M

59.38M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
Investor Event Transcript	2026-08-11	2026-09-30
8-K	2026-08-05	—
10-Q	2026-08-05	2026-06-30
8-K	2026-06-05	2026-06-04
Investor Event Transcript	2026-05-19	2026-06-30
10-Q	2026-05-06	2026-03-31
8-K	2026-05-06	—
DEF 14A	2026-04-20	2026-06-04
8-K	2026-03-16	2026-03-12
10-K	2026-03-09	2025-12-31
8-K	2026-03-09	2026-03-04
8-K	2025-12-17	2025-12-11
8-K	2025-12-02	2025-11-26
8-K	2025-11-20	—
10-Q	2025-11-05	2025-09-30
8-K	2025-11-05	—
10-Q	2025-08-12	2025-06-30
8-K	2025-08-12	—
8-K	2025-05-29	—
10-Q	2025-05-13	2025-03-31
8-K	2025-05-13	—
8-K	2025-04-07	2025-04-01
10-K	2025-03-12	2024-12-31
8-K	2025-03-11	—
8-K	2025-02-27	2025-02-26
8-K	2024-12-06	2024-12-02
8-K	2024-11-22	2024-11-21
10-Q	2024-11-13	2024-09-30
8-K	2024-11-12	—
8-K	2024-09-20	—
10-Q	2024-08-14	2024-06-30
8-K	2024-08-13	—
8-K	2024-08-09	2024-08-08
8-K	2024-08-08	—
8-K	2024-08-05	2024-08-02
8-K	2024-07-12	—
8-K	2024-07-09	—
8-K	2024-06-03	—
8-K	2024-05-13	—
10-Q	2024-05-09	2024-03-31
8-K	2024-05-08	—
8-K	2024-04-10	2024-04-04
DEF 14A	2024-04-03	2024-05-13
10-K	2024-04-01	2023-12-31
8-K	2024-03-28	—
8-K	2024-03-27	2024-03-26
8-K	2024-03-05	—
8-K	2024-03-04	—
8-K	2024-02-28	2024-02-22
8-K/A	2024-02-05	2023-11-20

Showing 1–50 of 155 filings

Key facts CIK 1434647 CUSIP 488445206 13F (30d) 124 filings 122 filers Visit website Investor relations